Abstract A histone acetyltransferase Tat-interacting protein 60 kDa (Tip60) regulates the DNA damage response by acetylating histone and remodeling chromatin. In addition to histone acetyltransferase activity, Tip60 is known to regulate a variety of cellular functions, including gene expression, DNA damage response, cell migration and apoptosis. Lower expression of Tip60 is observed in lymphomas, melanomas, breast, colon, and lung cancer. It is widely accepted that Tip60 functions as a tumor suppressor. However, a role of Tip60 in gliomas still remains unclear. In this study, we investigated the role of Tip60 in the malignant behavior of human gliomas. By quantitative RT-PCR analysis using fresh human brain tumor tissues from 55 patients, we found that lower Tip60 expression and higher membrane-type 1 matrix metalloproteinase (MT1-MMP) expression are associated with advanced tumor grade in glioma tissues. Knockdown of Tip60 in glioblastoma cells promoted cell adhesion, spreading and MT1-MMP transcription and thereby invasion, which was suppressed by inhibition of MT1-MMP and nuclear factorkappa B (NF-jB) activity. We demonstrate for the first time that tumor suppressor Tip60 down-regulates cell adhesion and MT1-MMP expression and thereby invasion of glioblastoma cells by suppressing NF-jB pathway.
Introduction
Tat-interacting protein 60 kDa (Tip60 also KAT5) is a member of the MOZ, Ybf2/Sas3, Sas2, and Tip60 (MYST) family of histone acetyltransferase (HAT) and regulates the DNA damage response by acetylating histone and remodeling chromatin [1] . Besides HAT activity on chromatin remodeling, Tip60 possesses more divergent functions in many cellular processes. In transcriptional regulation, Tip60 can activate gene expression through its HAT activity, or act as a corepressor by the recruitment of histone deacetylase (HDAC) or through interactions with the transcriptional repressor. It plays crucial roles in cellular response to DNA damage by interacting with the kinase ataxia telangiectasia-mutated (ATM) and DNA-dependent protein kinase catalytic subunit (DNA-PKcs) [2] . Also, Tip60 is a major component of the p53 pathway. It acetylates a specific lysine residue in DNA-binding domain of p53 following DNA damage, resulting in the activation of a subset of target genes that trigger apoptosis [3, 4] .
Loss of Tip60 is associated with a growing number of cancer types [5] . Lower expression of Tip60 is observed in lymphomas, melanomas, breast, colon, and lung cancer [5, 6] . Down-regulation of Tip60 gene expression in colorectal cancer is correlated with increasing tumor size, metastasis, and tumor stage [7] . Ectopic expression of Tip60 suppresses but its knockdown promotes melanoma migration [8] . Tip60 overexpression up-regulates gene expression of metastasis suppressor CD82 (KAI), resulting in the decrease of invasion in metastatic cancer cells [9] . The recent study has demonstrated that CD82 interferes with MT1-MMP-mediated MMP-2 activation by unknown mechanism [10] .
MT1-MMP, a first member of membrane-anchored MMP was originally identified as a tumor-specific MMP-2 activator [11] [12] [13] , and is now known to activate MMP-13 and degrade a wide range of extracellular matrix (ECM) components, including type I, II, III collagen, laminins, and fibronectin (FN) [13] . This enzyme also processes and interacts with membrane-tethered proteins such as integrins and CD44. Among MMPs, MT1-MMP is most closely associated with the invasive phenotype of human tumors. The inhibition of MT1-MMP suppresses tumor cell invasion both in vitro and in vivo. [13] [14] [15] . Thus, MT1-MMP is considered to play a significant role in tumor progression.
To investigate the role of Tip60 in the malignant behavior of human gliomas, the expression level of Tip60 was evaluated as a function of tumor grade in 55 surgical specimens. Our data indicate that lower expression of Tip60 is significantly associated with enhanced MT1-MMP expression and higher tumor grade. We also show that Tip60 knockdown facilitates cell attachment, spreading and transcription of MT1-MMP, and thereby promotes invasion of glioblastoma cells. Our findings provide insight into the molecular mechanism by which Tip60 functions as a tumor suppressor.
Methods

Cell culture and reagents
Human glioblastoma U87 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10 % FBS. Glass coverslips and FN were purchased from Asahi Techno Glass (Tokyo, Japan). A synthetic MMP inhibitor BB94 was a kind gift from the Kotobuki Pharmaceutical (Nagano, Japan). An anti-MT1-MMP antibody (Clone 222-3E12) was gifted by Daiichi Fine Chemicals (Toyama, Japan). NF-jB inhibitor BAY11-7082, PI3-K inhibitor LY294002, ROCK inhibitor Y27632, and MLCK inhibitor Blebbistatin were purchased from Merck Millipore (Temecula, CA, USA). The immunological reagents used were; anti-CD44, antiintegrin b 1 , anti-integrin a v , anti-Tip60, and anti-p21 Cip antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA); anti-Tip60, anti-integrin b 3 , and anti-p53 antibodies (Merck Millipore); anti-N-cadherin and anti-paxillin antibodies (BD Biosciences, Bedford, MA, USA); an anti-tubulin antibody (Sigma-Aldrich, St Louis, MO, USA); DAPI, rhodamine-phalloidin, and Alexa Fluorlabeled secondary antibodies (Molecular Probes, Eugene, OR, USA).
Clinical samples and histology
Following informed consent, fresh human brain tumor tissues were obtained from 55 patients who underwent therapeutic removal of gliomas at Kanazawa University Hospital as approved by the Institutional Review Board. Non-neoplastic control brain tissues were identified far from the tumor margins. The histoanalyses are based on the revised World Health Organization criteria [16] . The 55 gliomas consisted of 6 diffuse astrocytomas, 9 anaplastic astrocytomas, and 40 glioblastomas. All of the tumor tissues were obtained at primary resection, and none of the patients had been subjected to chemotherapy or radiation therapy before resection. Tissue samples were obtained and immediately frozen in liquid nitrogen. Samples were maintained at -80°C until use.
Quantitative real-time-PCR (QRT-PCR)
Total RNA was isolated from fresh tumor tissues or cultured cells using the Sepasol-RNA I Super (Nacalai Tesque, Kyoto, Japan) according to the manufacture's procedure. Reverse transcription of RNA was performed using the QuantiTect Reverse Transcription Kit (Quiagen, Valencia, CA, USA). Gene expression was quantified by QRT-PCR on a LightCycler using MasterPLUS SYBR Green (Roche Diagnostics, Penzberg, Germany) as described previously [17] . PCR was done with the following primers for tip60 (NM_182710): forward (5 0 -CAGGACAGCTCTGATGGA ATAC) and reverse (5 0 -AGAGGACAGGCAATGTGGTG AG); mt1-mmp (NM_004995): forward (5 0 -GGAATAA CCAAGTGATGGATGG) and reverse (5 0 -TTGTTTCCA CGGAAGAAGTAGG); b-actin (NM_001101): forward (5 0 -CTACAATGAGCTGCGTGTGGC) and reverse (5 0 -CAGG TCCAGACGCAGGATGGC). Hs_GAPDH_1_SG QuantiTect Primer (Qiagen) was used to monitor the amplification of GAPDH gene transcript as a control.
siRNA-mediated protein knockdown
The siRNA sequences were as follows: tip60, 5 0 -GUA CGGCCGUAGUCUCAAGdTdT; tip60-2, 5 0 -ACGGAAG GUGGAGGUGGUUdTdT [4] ; mt1-mmp, 5 0 -GCGAUGA AGUCUUCACUUAdTdT. As a control, siRNA duplex with an irrelevant sequence was used (Qiagen). U87 cells were transfected with 20 nM of siRNA duplexes in Opti-MEM using Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA, USA) for 48 h and cultured for further 24 h in fresh medium. The cells (1 9 10 5 cells/ml) were replated and cultured for 48 h, and then analyzed.
Immunoblotting
Cells were lyzed in 10 mM Tris-HCl (pH 7.5), 100 mM NaCl, 5 mM EDTA, 2 mM Na 3 VO 4 , 2 mM NaF, and 1 % SDS after washing with phosphate-buffered saline (PBS). Protein concentration was determined using BCA assay (Pierce Thermo Scientific, Rockford, IL, USA). Cell lysates were separated by electrophoresis on SDS-polyacrylamide gels and transferred onto nitrocellulose membranes. Membranes were reacted with the indicated antibodies. The signal was monitored using a Li-COR Odyssey IR imaging system (Lincoln, NE, USA).
Immunofluorescence staining
Cells were seeded and cultured on glass coverslips. After washing with PBS, the cells were fixed with 4 % paraformaldehyde, permeabilized with 0.5 % Triton X-100, stained with the indicated antibodies and then examined by confocal laser microscopy (Carl Zeiss, Jena, Germany).
Gelatin zymography
The conditioned media were analyzed with an SDS-polyacrylamide gel containing 0.1 % gelatin as described previously [12, 14] . Gelatinolytic activity of MMP-2 was detected as unstained bands on a blue background.
Cell attachment and spreading assay
For cell attachment assay, cells in suspension were allowed to adhere to FN-coated 96-well plates in complete media for 6 h, and then stained with 1 % crystal violet in methanol. After washing with PBS, the crystal violet was eluted with 10 % acetic acid and measured by absorption at 560 nm. For cell spreading assay, cells were suspended and allowed to adhere to FN-coated glass coverslips in complete media for 12 h and then stained.
Cell invasion assay
Cell invasion was assayed using modified Boyden chambers consisting of Transwell membrane filters (Corning Costar, Cambridge, MA, USA). Membranes were coated with 1 mg/ml of Matrigel (BD Biosciences). U87 cells (2 9 10 5 cells) were suspended in 0.5 % FBS/DMEM containing 2 mg/ml bovine serum albumin and poured added to the upper chamber. Lower chambers were filled with 10 % FBS/DMEM. After the cultivation incubation for 20 h, the number of crystal violet-stained cells on the lower surface was counted as described previously [15] .
Statistics
Statistical analyses were done using two-tailed MannWhitney U test. P \ 0.05 was considered significant.
Results
Tip60 expression is down-regulated in glioblastoma tissues and cells
To evaluate the potential role of Tip60 in the malignant behavior of human gliomas, the expression levels of Tip60 and MT1MMP were evaluated as a function of tumor grade in 55 surgical specimens. The mRNA levels of Tip60 and MT1-MMP in human normal brain and gliomas were evaluated by QRT-PCR using b-actin mRNA as the internal reference for normalization (Fig. 1a) . QRT-PCR analysis demonstrated that Tip60 mRNA levels (Tip60 mRNA: bactin mRNA ratios) were significantly lower in glioblastoma tissues (mean ± SD, 0.254 ± 0.090; n = 40) than in normal brain tissues (0.799 ± 0.143; p \ 0.001; n = 8), diffuse astrocytoma tissues (0.586 ± 0.193; p \ 0.001; n = 6) and anaplastic astrocytoma (0.431 ± 0.122; p \ 0.001; n = 9; Fig. 1a ). In contrast, the expression levels of MT1-MMP were significantly higher as tumor grade increased.
Furthermore, the expression levels of the Tip60 were lower in glioblastoma tissues obtained far from the necrosis of the tumors (0.25-to 0.52-fold) than those in normal brain tissues resected from the margins of the tumors in 5 cases of glioblastoma (Fig. 1b) . The expression levels of MT1-MMP were higher in glioblastoma tissues than in normal brain tissues. These results indicated the reverse correlation between Tip60 and MT1-MMP mRNA expression level in glioblastomas.
Tip60 knockdown promotes cell attachment and MMP-2 activation
In order to study the pathological significance of Tip60 down-regulation in glioblastoma cell lines, U87 cells were transfected with either control siRNA or siRNA for Tip60. Tip60 knock-downed cell showed a flat and large cell size compared with mock-transfected cells (Fig. 2a: left panel) . Immunoblot analysis revealed that Tip60 knockdown reduces p21
Cip1 expression and stimulates the expression of integrin b 3 and MT1-MMP (Fig. 2b) . The expression levels of p53, N-cadherin, integrin a v and b 1 were not changed. The expression of MT1-MMP protein was up-regulated by 4.1-fold in Tip60 knock-downed cells compared with mock-transfected cells (Fig. 2c) . The expression level of MT1-MMP mRNA was examined by real-time PCR quantification. Tip60 knockdown up-regulated MT1-MMP mRNA expression by 3.3-fold compared with mocktransfected cells (Fig. 2d) . In parallel with the increase of MT1-MMP level, gelatin zymography analysis showed that Tip60 knockdown promoted the activation of MMP-2 (Fig. 2a, b) , which was completely inhibited by doubleknockdown with MT1-MMP (data not shown). MMP-2 expression levels were not significantly altered, and MMP-9 expression levels were not affected either as detected by gelatin zymography. These results show that Tip60 knockdown up-regulates MT1-MMP expression, resulting in the promotion of MMP-2 activation.
The an integrin a v b 3 is known to contribute to cell attachment to vitronectin and FN. Concomitant with the increase of integrin b 3 expression by Tip60 knockdown, cell adherence onto FN-coated plates was augmented (Fig. 2e) . Immunofluorescence staining indicated that cell-ECM adhesions visualized by Paxillin staining and actinstress fibers were well organized and formed in Tip60-silenced U87 cells when cells were plated onto FN-coated coverslips (Fig. 2f) . These results show that the increase of integrin b 3 expression by Tip60 knockdown promotes cell attachment and spreading.
Tip60 knockdown promotes cell invasion
ECM degradation is one of important steps in invasion of brain tumors, in which MT1-MMP plays a central role [18, 19] . The effect of Tip60 knockdown on invasion into Matrigel was tested. In parallel with the enhancement of MT1-MMP-mediated MMP-2 activation by Tip60
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LGA AA GB NB (n=8) (n=6) (n=9) (n=40) LGA low-grade astrocytomas; AA anaplastic astrocytomas; GB glioblastomas; *p \ 0.05; **p \ 0.01; ***p \ 0.001. b Tip60 (left) and MT1-MMP (right) mRNA levels of tumor and normal brain tissues resected from the margins of the tumors in 5 cases of glioblastoma were analyzed as described above knockdown, invasion of U87 cells into Matrigel was drastically enhanced (Fig. 3a) . BB94 treatment interfered with invasion of Tip60-silenced cells, accompanying with the blockade of MMP-2 activation (Fig. 3b) . These results indicated that Tip60 knockdown promotes invasion of 
NFj-B inhibition reduces invasion of Tip60-silenced cells
To study the mechanism by which Tip60 knockdown upregulates MT1-MMP expression, we tested the effect of a variety of reagents that were reported to suppress MT1-MMP expression, including PI3 K inhibitor LY294002, ROCK inhibitor Y27632, Myosin II inhibitor Blebbistatin, and NFj-B inhibitor BAY11-7082, on MT1-MMP-mediated MMP-2 activation in Tip60 knock-downed cells. Only BAY11-7082 significantly suppressed MMP-2 activation in Tip60 knockdowned U87 cells (Fig. 4a) , which was accompanied with the abrogation of MT1-MMP induction (Fig. 4b, c) . It also interfered with induction of integrin b 3 and CD44, which are well known target genes of NFj-B, in Tip60-silenced U87 cells. Thus, the enhanced invasive phenotype of Tip60 knockdowned U87 cell was impeded by BAY11-7082 treatment (Fig. 4d) . These results suggest that Tip60 reduces invasive phenotype through suppression of NFj-B pathway.
Discussion
The correlations between the reduced expression of Tip60 and tumor progression have been studied in many tumors. Recent studies have revealed that inactivation of Tip60 leads to defective DNA repair and increases cancer risk [20] . Overexpression of Tip60 up-regulates gene expression of metastasis suppressor CD82, resulting in decreased invasion of metastatic cancer cells into Matrigel [9] . In this study, we found that Tip60 expression level shows the reverse correlation with the tumor grade and MT1-MMP level in human glioma tissues (Fig. 1) . Lower Tip60 expression may be associated with development and progression of gliomas. Present study demonstrated that Tip60 knockdown upregulates integrin b 3 expression, resulting in the enhancement of cell adhesion and spreading (Fig. 2) . Integrin a v b 3 is expressed on the most aggressive tumor cells in many cancers including high-grade glioma [21] , and its expression correlates with metastasis by recruiting c-Src to integrin b 3 [22] . Recent study has revealed that integrin b 3 is necessary and sufficient to account for stemness and drug resistance by activating Ras/RalB/TBK1/NF-jB pathway [23, 24] . Expression of integrin b 3 is induced by a variety of factors, including hypoxia and inflammatory stress, and is down-regulated by HDAC inhibitor that activates HAT [25] . Tip60 functions not only as a co-activator but also as a co-repressor [1] . Tip60 may negatively regulate cellular adhesiveness at least in part through suppression of integrin b 3 expression, which may activate NF-jB pathway.
MMP-2 activation has been correlated with invasive behavior of many tumors [13] . Knockdown of Tip60 upregulates the level of MT1-MMP mRNA and protein, resulting in the promotion of MMP-2 activation (Fig. 2) . Thus, Tip60 knockdown promoted U87 cell invasion into Matrigel, which was blocked by MMP inhibitor (Fig. 3) and NF-jB inhibitor (Fig. 4) . Consistent with our results, p38 MAPK-/NF-jB pathway up-regulates MT1-MMP expression [26, 27] . Tip60 directly interacts and acetylates p53, and thus modulates its stability and transcriptional activity. Loss of p53 function results in the constitutive activation of NF-jB [28, 29] . Knockdown of Tip60 downregulates the expression of p21 which is a target gene of p53 (Fig. 2) . Tip60 depletion may up-regulate NF-jB activity by down-regulating p53 activity (Fig. 4e) . Alternatively, Tip60 negatively regulates the gene expression by binding to signal transducers and activators of transcription 3 [30] , cAMP response element-binding protein [31] , and zinc finger E box-binding protein [32] which are all involved in tumor progression. Regulation of transcriptional factors by Tip60 may be a therapeutic approach for inhibition of tumor progression. Further studies are required to examine the molecular mechanism by which Tip60 regulates NF-jB activity.
NF-jB is activated, and its target genes are overexpressed in glioblastoma tissues. The higher NF-jB activity correlates with poor prognosis of glioblastoma patients [33] . We demonstrate here for the first time that tumor suppressor Tip60 negatively regulates cell adhesion and MT1-MMP expression in glioblastoma cells through NFjB pathway, resulting in suppression of invasiveness. It is widely accepted that either HDAC inhibition or HAT activation suppresses cancer cell invasion. Treatment with HDAC inhibitors reduces the MMP-2 expression and/or induces the expression of MMP inhibitors such as tissue inhibitor of metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs [34, 35] . Tip60/NFjB pathway may play a central role in regulation of invasiveness of gliomas.
In conclusion, our data indicate that Tip60 negatively regulates cell adhesion and MT1-MMP expression in glioblastoma cells through NF-jB pathway, which results in suppression of invasiveness. Tip60 may be a prognostic factor and a possible molecular target of gliomas.
